Current NDC auxiliary source row compounder:1387
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 81483-0041
- Product Ndc
- 81483-0041
- Product Ndc Digits
- 814830041
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- Avastin
- Proprietary Name Suffix
- Nonproprietary Name
- Bevacizumab
- Dosage Form Name
- INJECTION, SOLUTION
- Route Name
- INTRAVITREAL
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- Tailstorm Health INC DBA Medivant Healthcare
- Establishment Name
- Tailstorm Health INC DBA Medivant Healthcare
- Establishment Fei
- Substance Name
- BEVACIZUMAB
- Active Ingredients Info
- 1.25 mg/.05 mL
- History Active Ingredients Raw
- BEVACIZUMAB
- History Active Ingredients Info Raw
- 1.25 mg/.05 mL
- History Dosage Raw
- INJECTION, SOLUTION
- Dea Schedule
- Package Ndc Raw
- 81483-0041-5
- Package Ndc
- 81483-0041-5
- Package Ndc Digits
- 8148300415
- Package Ndc11
- 81483004105
- Package Description
- 5 SYRINGE, GLASS in 1 TRAY (81483-0041-5) > .05 mL in 1 SYRINGE, GLASS (81483-0041-1)
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:1387
- Source Row Number
- 1387
- Source Row Hash
- 0bd8d0a02abb77cb27c67bb4e95e0d8fed549983c79faf682dbcff01e4cc32b4
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45
Exact raw FDA source fields#
{
"ROUTENAME": "INTRAVITREAL",
"PRODUCTNDC": "81483-0041",
"DEASCHEDULE": "",
"LABELERNAME": "Tailstorm Health INC DBA Medivant Healthcare",
"SUBSTANCENAME": "BEVACIZUMAB",
"DOSAGEFORMNAME": "INJECTION, SOLUTION",
"NDCPACKAGECODE": "81483-0041-5",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "Avastin",
"REPORTINGPERIOD": "2026-1",
"NONPROPRIETARYNAME": "Bevacizumab",
"PACKAGEDESCRIPTION": "5 SYRINGE, GLASS in 1 TRAY (81483-0041-5) > .05 mL in 1 SYRINGE, GLASS (81483-0041-1) ",
"ACTIVEINGREDIENTSINFO": "1.25 mg/.05 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:1387
- Source Row Number
- 1387
- Status Scope
- package
- Lookup Ndc
- 81483-0041-5
- Lookup Ndc Digits
- 8148300415
- Product Ndc
- 81483-0041
- Product Ndc Digits
- 814830041
- Package Ndc
- 81483-0041-5
- Package Ndc Digits
- 8148300415
- Package Ndc11
- 81483004105
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- 0bd8d0a02abb77cb27c67bb4e95e0d8fed549983c79faf682dbcff01e4cc32b4
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45